ACS CAN Policy Event Rhode Island

12th Annual ACS CAN Rode Island Research Breakfast

September 30, 2025
Warwick, RI
Days
Hours
Minutes
Seconds

12th Annual ACS CAN
Rhode Island Research Breakfast

Tuesday, September 30, 2025
Crowne Plaza Providence-Warwick
801 Greenwich Ave, Warwick, RI 02886
7:30am – 9:30am

Event Information Text

Committee


Photo of Bernard A. Jackvony

Bernard A. Jackvony

Committee Chair

Bernard A. Jackvony is a nationally recognized fiduciary litigator and Of Counsel with Pannone Lopes Devereaux & O’Gara LLC. He concentrates his practice in the areas of trust and estate planning, litigation and administration for individuals, families, fiduciaries and charitable organizations and has represented clients in fiduciary litigation in Rhode Island, Florida, New Jersey, California, New York, Massachusetts and Oklahoma. Mr. Jackvony served the citizens of Rhode Island as Lieutenant Governor in the late 1990s and is a former member of the National Republican Committee, the Rhode Island State Investment Commission and Chairman of the Rhode Island Criminal Justice Oversight Commission.

 

With a strong commitment to public service and advancing the quality of life for others, Mr. Jackvony has been a volunteer with the American Cancer Society for over 30 years, including serving on the Board of Directors of the American Cancer Society Cancer Action Network, the New England Division Board of Directors and former member of the Florida Division Board of Directors. He is also a former member of the Board of Directors of the Oncology Nursing Society Foundation.

 

Attorney Jackvony earned his J.D. from Suffolk University, his master’s degree in taxation from Boston University and his undergraduate degree in accounting from Bryant University. He served as a member of the Board of Trustees at Bryant University for nine years and has assisted the university in its transition to a fully accredited international business school. Mr. Jackvony served as a Captain in the United States Marine Corps from 1970 to 1973. He is admitted to practice law in Rhode Island and Florida.

The American Cancer Society Cancer Action Network

The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the cancer burden for everyone. We engage our volunteers across the country to make their voices heard by policymakers at every level of government. We believe everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer.

Our Mission

Advocating to Help Save Lives from Cancer

Since 2001, as the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures.

We stand with our volunteers—people whose lives have been impacted by cancer—rallying to demand change. Together, we’re working to make cancer a top priority for public officials and candidates at the federal, state, and local levels. By engaging advocates across the country to make their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it, for everyone.

Learn More

ACS CAN is Committed to

ACS CAN’s policy priorities focus on improving the health of our community. They include:

Our Impact

23 Years
Of Wins Against Cancer

For more than 2 decades, the American Cancer Society Cancer Action Network has been dedicated to pursing better outcomes for every cancer, every life. Today, more people are surviving cancer than ever before, but there is still work to be done. Join us, support us, and help us end cancer as we know it, for everyone.

$ 4.8 B
Cancer Research

Protected and secured $4.8 billion in state appropriations through advocacy to help fund cancer research and programs that reduce the tobacco burden and increase access to screenings.

220 K
Retail Outlets

Held the tobacco industry responsible for decades of public deceit through a requirement for companies to post truthful statements about their deadly products at nearly 220,000 retail outlets nationwide.

10
Insurance Coverage

Expand insurance coverage of comprehensive biomarker testing in over 20 states and counting.

Want to get involved?

Learn More